Probiotics for preventing urinary tract infections in adults and children

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 12, 2015, Pages

  Schwenger, Erin M ^a   Tejani, Aaron M ^a   Loewen, Peter S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; CONSTIPATION; CRANBERRY JUICE; DIARRHEA; DISEASE PREDISPOSITION; HUMAN; MORBIDITY; MORTALITY RATE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); TREATMENT WITHDRAWAL; URINARY TRACT INFECTION; VOMITING; ADULT; BACTERIAL INFECTIONS; CHILD; FEMALE; MALE; META ANALYSIS; URINARY TRACT INFECTIONS;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; FEMALE; HUMANS; MALE; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY TRACT INFECTIONS;

EID: 84962392552     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008772.pub2     Document Type: Review

References (54)

1. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care 1994;12(4):239-43. [MEDLINE: 7863140]
2. Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics & Gynecology 2007;2007:35387. [MEDLINE: 18288237]
3. Ferrara P, Romaniello L, Vitelli O, Gatto A, Serva M, Cataldi L. Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology & Nephrology 2009;43(5):369-72. [MEDLINE: 19921981]
4. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322(7302):1-5. [MEDLINE: 11431298]
5. Lee SJ, Kim HJ, Shim YH, Lee JW. The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD. PP 81]. Pediatric Nephrology 2006;21(10):1542. [CENTRAL: CN-00724966]
6. Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology 2007;22(9):1315-20. [MEDLINE: 17530295]
7. Beerepoot MA, Stobberingh EE, Geerlings SE. A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study) [Onderzoek naar niet-antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI-studie)]. Nederlands Tijdschrift voor Geneeskunde 2006;150(10):574-5. [MEDLINE: 16566424]
8. Beerepoot MA, Ter Riet G, Nys S, van der Wal WM, De Borgie CAJM, de Reijke TM, et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non-in feriority'-studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde 2013;157(10):A5674. [EMBASE: 2013248979]
9. Beerepoot MA, Ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine 2012;172(9):704-12. [MEDLINE: 22782199]
10. Beerepoot MA, den Heijer CD, Penders J, Prins JM, Stobberingh EE, Geerlings SE. Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology & Infection 2012;18(4):E84-90. [MEDLINE: 22329638]
11. Beerepoot MA, van der Wal WM, Nys S. Lactobacillus rhamnosus gr-1 and l. Reuteri rc-14 versus trimethoprim-sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double-blind non-inferiority trial [abstract no: L1-1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12-15; San Francisco (CA). 2012.
12. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics 1992;14(1):11-6. [MEDLINE: 1576619]
13. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology & Medical Microbiology 2003;35(2):131-4. [MEDLINE: 12628548]
14. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases 2011;52(10):1212-7. [MEDLINE: 21498386]
15. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Israel Medical Association Journal: Imaj 2003;5(11):767-9. [MEDLINE: 14650098]
16. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biology of the Neonate 2002;82(2):103-8. [MEDLINE: 12169832]
17. Manley K, Fraenkel M, Mayall B, Power D. Yoghurt and VRE: Can a probiotic make a difference? [abstract no: 007]. Journal of Renal Nutrition 2008;18(3 Suppl 1):S3.
18. Manley KJ, Fraenkel MB, Mayall BC, Power DA. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Medical Journal of Australia 2007;186(9):454-7. [MEDLINE: 17484706]
19. Mohseni MJ, Aryan Z, Emamzadeh-Fard S, Paydary K, Mofid V, Joudaki H, et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics 2013;23(4):430-8. [MEDLINE: 24427497]
20. Molander U, Milsom I, Ekelund P, Mellstrom D, Eriksson O. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas 1990;12(2):113-20. [MEDLINE: 2255263]
21. NCT00900653. Low dose estriol with lactobacilli (Gynoflor) treatment for preventing recurrent urinary tract infection in postmenopausal women: a randomized, open, parallel-group study. www.clinicaltrials.gov/ct2/show/NCT00900653 (accessed 21 September 2015).
22. Pushkarev AM. Efficacy of probiotic bactisporin in therapy of intrahospital urinary infection. Urologiia (Moscow, Russia) 2005, (4):48-53. [MEDLINE: 16158748]
23. Ranganathan N, Friedman EA, Tam P, Rao V, Ranganathan P, Dheer R. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Current Medical Research & Opinion 2009;25(8):1919-30. [MEDLINE: 19558344]
24. Ranganathan N, Ranganathan P, Friedman EA, Joseph A, Delano B, Goldfarb DS, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Advances in Therapy 2010;27(9):634-47. [MEDLINE: 20721651]
25. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecology & Therapy 1995;23:32-45.
26. Skerk V, Ferincevic R, Markotic A, Andrasevic S, Milosevic V, Vargovic M, et al. Research on the efficacy of prophylactic use of Acidosalus probiotic in women with recurrent cystitis [Ispitivanje djelotvornosti profilakticke primjene probiotika Acidosalus u zena s rekurentnim cistitisom]. Infektoloski Glasnik 2010;30(1):21-5. [EMBASE: 2010599396]
27. NCT00781625. Probiotics/lactobacillus as a prophylactic aid in recurrent bacterial cystitis in women. a randomized, prospective, double-blinded, placebo controlled, multi-center study. www.clinicaltrials.gov/ct2/show/NCT00781625 (accessed 21 September 2015).
28. Toh SL, Lee BS, Ryan S, Simpson J. Prophylaxis of spinal cord injury urinary tract infection therapeutic trial (ProSCIUTTU): protocol [abstract]. 53rd ISCoS Annual Scientific Meeting; 2014 Sept 2-4; Maastricht, Netherlands. 2014.
29. Albert X, Huertas I, Pereiró I, Sanfélix J, Gosalbes V, Perrotta C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD001209.pub2]
30. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for the prevention of recurrent urinary tract infections. Canadian Journal of Microbiology 1988;34(3):339-43. [MEDLINE: 3138016]
31. Centers for Disease Control and Prevention (CDC). Monitoring hospital-acquired infections to promote patient safety--United States, 1990-1999.[Erratum appears in MMWR Morb Mortal Wkly Rep 2000 Mar 10;49(9):189-90]. MMWR - Morbidity & Mortality Weekly Report 2000;49(8):149-53. [MEDLINE: 10737441]
32. Christensen J, Jepsen OB. Reduced rates of hospital acquired UTI in medical patients. Prevalence surveys indicate effect of active infection control programmes. Journal of Hospital Infection 2001;47(1):36-40. [MEDLINE: 11161896]
33. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy 2006;58(2):266-72. [MEDLINE: 16790461]
34. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-a-Month 2003;49(2):53-70. [MEDLINE: 12601337]
35. Grin PM, Kowalewska PM, Alahazanni W, Fox-Robichaud AE. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Canadian Journal of Urology 2013;20(1):6607-14. [MEDLINE: 23433130]
36. Hawthorn LA, Reid G. Exclusion of uropathogen adhesion to polymer surfaces by Lactobacillus acidophilus. Journal of Biomedical Materials Research 1990;24(1):39-46. [MEDLINE: 2105962]
37. Heinemann C, van Hylckama Vlieg JE, Janssen DB, Busscher HJ, van der Mei HC, Reid G. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131. FEMS Microbiology Letters 2000;190(1):177-80. [MEDLINE: 10981710]
38. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
39. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
40. Howes DS. Urinary tract infections, female. emedicine.medscape.com/article/778670-overview (accessed August 2010).
41. Howes DS, Pillow MT. Urinary tract infections, male. emedicine.medscape.com/article/778578-overview (accessed August 2010).
42. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD001321.pub5]
43. Maki D, Tambyah PA. Engineering out the risk of infection with urinary catheters. Emerging Infectious Diseases 2001;7(2):342-7. [MEDLINE: 11294737]
44. Osset J, Bartolome RM, Garcia E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. Journal of Infectious Diseases 2001;183(3):485-91. [MEDLINE: 11133381]
45. Ouslander JG, Schnelle JF, Uman G, Fingold S, Nigam JG, Tuico E, et al. Predictors of successful prompted voiding among incontinent nursing home residents. JAMA 1995;273(17):1366-70. [MEDLINE: 7715062]
46. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005131.pub2]
47. Richards C, Emori TG, Peavy G, Gaynes RP. Promoting quality through measurement of performance and response: prevention success stories. Emerging Infectious Diseases 2001;7(2):299-301. [MEDLINE: 11294728]
48. Richards CL. Urinary tract infections in the frail elderly: Issues for diagnosis, treatment and prevention. International Urology & Nephrology 2004;36(3):457-63. [MEDLINE: 15783124]
49. Saint S, Wiese J, Amory JK, Bernstein ML, Patel UD, Zemencuk JK, et al. Are physicians aware of which of their patients have indwelling urinary catheters?. American Journal of Medicine 2000;109(6):476-80. [MEDLINE: 11042237]
50. Schnelle JF, McNees P, Crooks V, Ouslander JG. The use of a computer-based model to implement an incontinence management program. Gerontologist 1995;35(5):656-65. [MEDLINE: 8543223]
51. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics - approaching a definition. American Journal of Clinical Nutrition 2001;73(2 Suppl):361S-364S. [MEDLINE: 11157342]
52. Velraeds MM, van de Belt-Gritter B, van der Mei HC, Reid G, Busscher HJ. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. Journal of Medical Microbiology 1998;47(12):1081-5. [MEDLINE: 9856644]
53. Williams G, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD001534.pub3]
54. Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD008772]